Healthcare Trust Reduces Distribution Rate

March 10, 2017


Healthcare Trust Reduces Distribution Rate

March 10, 2017 | by James Sprow | Blue Vault


On March 3, 2017, the board of directors of Healthcare Trust, Inc., a nontraded REIT sponsored by AR Global, authorized a decrease in the rate at which the Company pays monthly distributions to holders of the Company’s common stock, effective as of April 1, 2017, from $0.0046575343 per share per day, or $1.70 per share on an annualized basis, to $0.0039726027 per share per day, or $1.45 per share on an annualized basis. This represents a change in the annualized distribution yield, based on the original purchase price of $25.00 per share, from 6.8% to 5.8%, or a change from 7.6% to 6.5% based on the Company’s most recent estimated value per share as of December 31, 2015 of $22.27 per share.

Due to the strategic review in 2016, the board delayed redemptions in 2016 and as a result redemptions for the full year will be paid out on or before March 15, 2017. Per the approval of the REIT’s board, redemptions for 2016 will be equal to 1.5% of weighted average shares outstanding in 2015, representing less than all redemption requests but honoring all death and disability requests. The redemptions for 2017 will be considered on a semi-annual basis and will remain subject to board review and amendment.

In a stockholder presentation filed with the SEC on March 9, the REIT stated that it plans to grow its portfolio and increase leverage to more closely align the nontraded REIT with publicly traded healthcare REITs and be better positioned for a future liquidity event. 


Learn more about AR Global on our Sponsor Focus page. 

Click Here


Print Friendly, PDF & Email
Go Back
John E. Moriarty, ChFC
December 2015
February 3, 2016

I have been in the financial services industry for 20 years and our firm provides an education platform that gets clients to “think differently” about their financial picture.  For many years we have communicated to clients the need to diversify their portfolios using alternative asset classes and more specifically, private non-traded investments.  Due diligence on these types of financial vehicles is essential and when I learned about Blue Vault in 2010, our firm immediately began using their material as a tool to build confidence in the minds of our advisors on which alternatives to recommend to clients.  I am impressed with the way Blue Vault continues to add value to their subscribers and I view their publication as a tremendous resource in today’s complex world.